MAPT and Alzheimer disease: By comparison, Aβ‐PET SUVR could predict dementia progression no matter whether CSF tau was positive or negative (Figure S2d–f), suggesting Aβ‐PET was an independently reliable predictor of cognitive decline in the AD continuum (Table S6).